Company intelligence / Profile preview

Sonix Medical Devices

Huntington Beach, California, United Statesventureradar.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Sonix-A8 is a patented non-pharmaceutical device that uses photodynamic therapy combined with ultra-high frequency sound to selectively kill bacteria—including drug-resistant strains—without harming human cells. It is designed to prevent and control surgical site and hospital-acquired infections, offering an alternative to antibiotics in the fight against antimicrobial resistance. The company claims broad-spectrum efficacy including against superbugs like MRSA. No published clinical trial results were identified; the focus appears to be on rapid deployment into healthcare environments.

Therapeutic areas: Infectious Diseases
Modalities: DevicePhotodynamic therapyUltra-high frequency sound technology
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Sonix Medical Devices.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sonix Medical Devices.

Explore the full profile